That said, Recursion doesn't have a single therapy on the market yet. Over the past four years, the company has made little notable clinical progress. Like most clinical-stage biotechs, Recursion ...

Next year’s Java release is slated to include a performance boost for the G1 garbage collector and opt-in support for HTTP/3.

The Java virtual machine manages application memory and provides a portable execution environment for Java-based applications. Developers reap the rewards in performance, stability, and predictable ...

One of the first things about Minecraft you’ll notice is needing to decide which type or version to use. Bedrock and Java exist and to the untrained eye, neither ...

Recursion Pharmaceuticals reported significant growth in sales and revenue for Q2 and the first half of 2025 but also experienced widening net losses. The release of their Boltz-2 model underscored a ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 10 Best Penny Stocks to Buy for the Next 5 Years. On August 5, Needham reiterated its Buy rating on Recursion Pharmaceuticals, Inc.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Oracle has released version 25 of the Java programming language and virtual machine. As the first LTS release since JDK 21, ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...